CGON
Price
$25.53
Change
-$0.75 (-2.85%)
Updated
Jun 20, 04:59 PM (EDT)
Capitalization
1.95B
48 days until earnings call
REPL
Price
$9.27
Change
-$0.22 (-2.32%)
Updated
Jun 20 closing price
Capitalization
714.59M
40 days until earnings call
Interact to see
Advertisement

CGON vs REPL

Header iconCGON vs REPL Comparison
Open Charts CGON vs REPLBanner chart's image
CG Oncology
Price$25.53
Change-$0.75 (-2.85%)
Volume$11.69K
Capitalization1.95B
Replimune Group
Price$9.27
Change-$0.22 (-2.32%)
Volume$1.47M
Capitalization714.59M
CGON vs REPL Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. REPL commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and REPL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2025
Stock price -- (CGON: $25.55 vs. REPL: $9.27)
Brand notoriety: CGON and REPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 71% vs. REPL: 116%
Market capitalization -- CGON: $1.95B vs. REPL: $714.59M
CGON [@Biotechnology] is valued at $1.95B. REPL’s [@Biotechnology] market capitalization is $714.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.21B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileREPL’s FA Score has 1 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • REPL’s FA Score: 1 green, 4 red.
According to our system of comparison, REPL is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 2 TA indicator(s) are bullish while REPL’s TA Score has 5 bullish TA indicator(s).

  • CGON’s TA Score: 2 bullish, 3 bearish.
  • REPL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, REPL is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а -1.20% price change this week, while REPL (@Biotechnology) price change was -5.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.70%. For the same industry, the average monthly price growth was +28.03%, and the average quarterly price growth was +14.56%.

Reported Earning Dates

CGON is expected to report earnings on Aug 07, 2025.

REPL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+9.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($1.95B) has a higher market cap than REPL($715M). CGON YTD gains are higher at: -8.368 vs. REPL (-23.452). CGON has higher annual earnings (EBITDA): -134.35M vs. REPL (-235.43M). CGON has more cash in the bank: 688M vs. REPL (484M). CGON has less debt than REPL: CGON (1.04M) vs REPL (76.2M). CGON has higher revenues than REPL: CGON (662K) vs REPL (0).
CGONREPLCGON / REPL
Capitalization1.95B715M272%
EBITDA-134.35M-235.43M57%
Gain YTD-8.368-23.45236%
P/E RatioN/AN/A-
Revenue662K0-
Total Cash688M484M142%
Total Debt1.04M76.2M1%
FUNDAMENTALS RATINGS
REPL: Fundamental Ratings
REPL
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONREPL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 15 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTTRX29.27N/A
N/A
Goldman Sachs Small Cp Val Insghts R
HSSIX29.31N/A
N/A
Emerald Finance & Bking Innovt Fd Instl
IEIFX10.67N/A
N/A
Invesco Equity and Income R6
MMFFX13.54N/A
N/A
MM S&P 500® Index A
DESCX21.72N/A
N/A
DWS ESG Core Equity C

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+0.15%
IDYA - CGON
60%
Loosely correlated
-0.27%
ACLX - CGON
56%
Loosely correlated
-0.42%
SYRE - CGON
56%
Loosely correlated
-0.66%
NUVL - CGON
55%
Loosely correlated
-0.70%
KYMR - CGON
54%
Loosely correlated
+0.19%
More